Fed. Circ. Says UK DNA Sequencers Don't Infringe IP In US

Law360 (February 12, 2019, 7:43 PM EST) -- The Federal Circuit on Tuesday affirmed a determination by the U.S. International Trade Commission that DNA sequencers imported by U.K. company Oxford Nanopore Technologies do not violate two patents held by Silicon Valley-based Pacific Biosciences of California.

The three-judge panel's one-sentence order did not expand on its rationale for affirming the ITC's February 2017 decision that Oxford did not violate Section 337 of the Tariff Act of 1930 by importing or selling certain single-molecule nucleic acid sequencing systems and related products.

Pacific Biosciences had told the ITC in October 2016 that Oxford's MinION and PromethION model DNA sequencers infringed one of...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!